Emcure Pharma Delivers Strong Q1 on Overseas Growth

Emcure Pharmaceuticals reported a robust Q1 FY27, with net profit rising 36.2% YoY to ₹292 crore on the back of strong international business, higher operating leverage and productivity gains. Revenue increased 22.8% to ₹2,580 crore, while EBITDA margin improved 50 basis points to 19.7%, reflecting stronger profitability. $EMCURE